BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8963159)

  • 21. To stop or not? Tamoxifen therapy for secondary prevention of breast cancer in a patient with ocular toxicity.
    Bommireddy T; Carrim ZI
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26759403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tamoxifen retinopathy: does it really exist?
    Lazzaroni F; Scorolli L; Pizzoleo CF; Savini G; De Nigris A; Giosa F; Meduri RA
    Graefes Arch Clin Exp Ophthalmol; 1998 Sep; 236(9):669-73. PubMed ID: 9782427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tamoxifen retinopathy.
    Kaiser-Kupfer MI; Lippman ME
    Cancer Treat Rep; 1978 Mar; 62(3):315-20. PubMed ID: 647693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eye problems in breast cancer patients treated with tamoxifen.
    Paganini-Hill A; Clark LJ
    Breast Cancer Res Treat; 2000 Mar; 60(2):167-72. PubMed ID: 10845279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity: a prospective study of 63 patients.
    Flach AJ
    Surv Ophthalmol; 1994; 38(4):392-3. PubMed ID: 8160114
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse ocular reactions to drugs.
    Spiteri MA; James DG
    Postgrad Med J; 1983 Jun; 59(692):343-9. PubMed ID: 6356101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudocystic foveal cavitation in tamoxifen retinopathy.
    Doshi RR; Fortun JA; Kim BT; Dubovy SR; Rosenfeld PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1291-1298.e3. PubMed ID: 24582991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rare case: Branch retinal vein occlusion associated with the use of tamoxifen.
    Demirci NS; Erdem GU; Uçgun Nİ; Bozkaya Y; Ozdemir NY; Dogan M; Zengin N
    J Cancer Res Ther; 2019; 15(3):722-724. PubMed ID: 31169251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Birdshot chorioretinopathy associated with tamoxifen retinal toxicity].
    Sommer S; Badet JC; Zaoui M; Naoun-Hubert I; Rozot P
    J Fr Ophtalmol; 2000 May; 23(5):494-7. PubMed ID: 10844311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen maculopathy: The importance of screening and long follow-up.
    Zamorano Martín F; Rocha-de-Lossada C; Rachwani Anil R; Borroni D; Rodriguez Calvo de Mora M; España Contreras M
    J Fr Ophtalmol; 2020 Oct; 43(8):727-730. PubMed ID: 32620415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen retinopathy in a male patient.
    Yanyali AC; Freund KB; Sorenson JA; Slakter JS; Wheatley HM
    Am J Ophthalmol; 2001 Mar; 131(3):386-7. PubMed ID: 11239879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular symptoms and signs associated with suramin sodium treatment for metastatic cancer of the prostate.
    Hemady RK; Sinibaldi VJ; Eisenberger MA
    Am J Ophthalmol; 1996 Mar; 121(3):291-6. PubMed ID: 8597272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystalline maculopathy: a rare complication of tamoxifen therapy.
    Srikantia N; Mukesh S; Krishnaswamy M
    J Cancer Res Ther; 2010; 6(3):313-5. PubMed ID: 21119261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible ocular toxicity related to tamoxifen therapy.
    Ashford AR; Donev I; Tiwari RP; Garrett TJ
    Cancer; 1988 Jan; 61(1):33-5. PubMed ID: 3334951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OCT Angiography Findings of Tamoxifen Retinopathy: Similarity with Macular Telangiectasia Type 2.
    Lee S; Kim HA; Yoon YH
    Ophthalmol Retina; 2019 Aug; 3(8):681-689. PubMed ID: 31068263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effects of Adjuvant Tamoxifen Use on Macula Pigment Epithelium Optical Density, Visual Acuity and Retinal Thickness in Patients with Breast Cancer.
    Bicer T; Imamoglu GI; Caliskan S; Bicer BK; Gurdal C
    Curr Eye Res; 2020 May; 45(5):623-628. PubMed ID: 31684771
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and in vivo confocal microscopy findings in patients receiving tamoxifen citrate.
    Muftuoglu O; Uçakhan OO; Kanpolat A
    Eye Contact Lens; 2006 Sep; 32(5):228-32. PubMed ID: 16974155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ocular side effects of drugs].
    Müller-Breitenkamp U; Hockwin O
    Laryngorhinootologie; 1992 Apr; 71(4):226-8. PubMed ID: 1575856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectral Domain OCT Imaging Techniques in Tamoxifen Retinopathy.
    Neuville J; Yevseyenkov V
    Optom Vis Sci; 2015 Feb; 92(2):e55-9. PubMed ID: 25525894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for ocular toxicity in asymptomatic patients treated with tamoxifen.
    Kalina RE; Wells CG
    Am J Ophthalmol; 1995 Jan; 119(1):112-3. PubMed ID: 7825684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.